Key result
PON1 55LL genotype linked to ~78% higher ischemic stroke risk.
Why the study?
Are PON1 genetic polymorphisms and enzyme activities associated with the risk of ischemic stroke in a Turkish population?
Case-Control (n=277)
Are PON1 genetic polymorphisms and enzyme activities associated with the risk of ischemic stroke in a Turkish population?
Odds Ratio: 1.78
PON1 genotypes, specifically -107TT and 55LL, but not enzyme activities, are associated with an increased risk of ischemic stroke in the Turkish population.
PON1 genotypes may flag elevated stroke risk in elderly Turks; leaves open whether testing guides prevention beyond this cohort.
BACKGROUND: Paraoxonase1 (PON1) is protective against the development of atherosclerosis, a risk factor for ischemic stroke. PON1 gene has one promoter region (-107T/C) and two coding region (192Q/R and 55L/M) polymorphisms that affect the levels and catalytic efficiency of the enzyme, respectively. In this study, we aimed to determine the importance of -107T/C, 192Q/R and 55L/M polymorphisms of PON1 gene and three PON1 activities (diazoxonase, paraoxonase, arylesterase) as risk factors for ischemic stroke. METHODS: Study population was comprised of 172 unrelated adult Caucasian patients with acute hemispheric ischemic stroke and 105 symptom-free controls. Genotypes were attained by PCR followed by restriction enzyme digestion and phenotypes were determined by spectrophotometric assays. RESULTS: This is the first study analyzing diazoxonase activity as a risk factor for ischemic stroke. Nevertheless, diazoxonase, paraoxonase and arylesterase activities were almost the same in stroke patients and controls. The -107TT genotype was associated with a 1.97 times increased risk for stroke in elderly (age > 59). Individuals with this genotype were found to have the lowest PON1 enzyme activities among the -107T/C genotypes. Triple combined haplotype QRLMTC was found to be 6.94- and 10.4-times protective against ischemic stroke in the overall and the elderly population, respectively. 55LL genotype was associated with a 1.78-fold increase in the risk of ischemic stroke. CONCLUSION: PON1 genotypes, but not activities, are related with the risk of stroke.
No takes yet. Share an insight, caveat, or question.
Demirdöğen et al. (2009) conducted a case-control in Ischemic stroke (n=277). PON1 genetic polymorphisms (-107T/C, 192Q/R, 55L/M) vs. Reference genotypes was evaluated on Ischemic stroke (OR 1.78). The PON1 55LL genotype was associated with a 1.78-fold increased risk of ischemic stroke, and the -107TT genotype increased risk 1.97-fold in the elderly, while enzyme activities showed no effect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: